The robust growth trajectory of the malaria vaccine segment is heavily reliant on the escalating flow of global investment and collaborative funding from public-private partnerships. Major international organizations, government agencies, and philanthropic bodies like the WHO, Gavi, and the Bill & Melinda Gates Foundation are significantly increasing their financial commitments to malaria...